Back to Search
Start Over
Depot buprenorphine injections for opioid use disorder: Patient information needs and preferences
- Source :
- Drug and Alcohol Review, Neale, J, Tompkins, C N E & Strang, J S 2019, ' Depot buprenorphine injections for opioid use disorder : Patient information needs and preferences ', Drug and Alcohol Review, vol. 38, no. 5, pp. 510-518 . https://doi.org/10.1111/dar.12939
- Publication Year :
- 2019
- Publisher :
- John Wiley & Sons Australia, Ltd, 2019.
-
Abstract
- Introduction and Aims: There has been significant recent investment in new medications for opioid use disorder, including buprenorphine depot injections. Patients and professionals need good quality, independent information on medications to help them make informed treatment decisions. This paper aims to understand patients’ information needs and preferences in relation to buprenorphine depot injections. Design and Methods: Semi-structured qualitative interviews were conducted with 36 people using opioids (26 men, 10 women; 24–63 years). Twelve participants were currently prescribed daily oral methadone; 12 were currently prescribed daily oral buprenorphine; and 12 were using heroin and not in treatment. Interviews were transcribed, coded and analysed via Iterative Categorisation. Results: Participants asked many questions about depot buprenorphine injections. These related to: (i) medication purpose and availability; (ii) pharmacology; (iii) evidence base and effectiveness; (iv) safety and side effects; (v) administration and dosing; and (vi) reducing and ending treatment. Additionally, participants expressed their information preferences in terms of (i) ‘format’ and (ii) ‘source’. Specifically, they wanted printed, verbal and electronic materials provided by people in authority, particularly patients who had already had the medication. Discussion and Conclusions: All potential patients should be offered accessible information on depot buprenorphine to enable them to consider their options and participate meaningfully in treatment decision making. We recommend that further qualitative research is undertaken to produce informative video material that describes patient experiences of receiving depot buprenorphine. This should help to balance biomedical knowledge with lay knowledge, so facilitating more informed discussions when decisions about depot buprenorphine treatment are made.
- Subjects :
- Adult
Male
medicine.medical_specialty
Health (social science)
Narcotic Antagonists
030508 substance abuse
Medicine (miscellaneous)
Information needs
Heroin
information
03 medical and health sciences
Young Adult
0302 clinical medicine
Patient information
Opiate Substitution Treatment
Medicine
Humans
030212 general & internal medicine
Dosing
Original Paper
Health Services Needs and Demand
business.industry
Opioid use disorder
Patient Preference
Middle Aged
medicine.disease
Opioid-Related Disorders
Original Papers
Buprenorphine
qualitative method
Family medicine
extended release buprenorphine
opioid
Female
0305 other medical science
business
heroin
Methadone
medicine.drug
Qualitative research
Subjects
Details
- Language :
- English
- ISSN :
- 14653362 and 09595236
- Volume :
- 38
- Issue :
- 5
- Database :
- OpenAIRE
- Journal :
- Drug and Alcohol Review
- Accession number :
- edsair.doi.dedup.....448c7384348e6c1947e19fad495da849